Back to homepage

Tag: Fecal therapy

Fecal therapy for CDI

A Fecal-Based Therapy To Prevent Recurrent C. diff Infection Is The First FDA-Approved Microbiome Therapeutic

The Food and Drug Administration recently approved a fecal-based therapy to prevent recurrent Clostridioides difficile infection. Rebyota is a drug that is approved for the prevention of recurring C. dificile infection also known as CDI in individuals of 18 year old and above.

Read Full Article

Follow us on Facebook